Vulval Carcinoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8/FIGO are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.
Hirschowitz L, Nucci M, Zaino RJ. Problematic issues in the staging of endometrial, cervical and vulval carcinomas. Histopathology. 2013;62:176–202.CrossRefGoogle Scholar
Kurman RJ, Norris HJ, Wilkinson E. Tumors of the cervix, vagina and vulva, Atlas of tumor pathology, vol. 3. Washington, DC: AFIP; 1992.Google Scholar
McAlpine JN, Leung SC, Cheng A, Miller D, Talhouk A, Gilks CB, et al. Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV- associated disease: a retrospective cohort study. Histopathology. 2017;71:238–46.CrossRefGoogle Scholar
McCluggage WG. Recent developments in vulvovaginal pathology. Histopathology. 2009;54:156–73.CrossRefGoogle Scholar
McCluggage WG. Ten problematic issues identified by pathology review for multidisciplinary gynaecological oncology meetings. J Clin Pathol. 2012;65:293–301.CrossRefGoogle Scholar
McCluggage WG, Hirschowitz L, Ganesan R, Kehoe S, Nordin A. Which staging system to use for gynaecological cancers: a survey with recommendations for practice in the UK. J Clin Pathol. 2010;63:768–70.CrossRefGoogle Scholar